Advertisement
Screener

BIO-TECHNE Corp (TECH) Common Stock Dividends Paid

2.8 / 5 stars · 68/120 Roast Me

BIO-TECHNE Corp Common Stock Dividends Paid

BIO-TECHNE Corp (TECH) reported Common Stock Dividends Paid of $49.92 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-24.

Financial Statements › Cash Flow › Financing Activities

us-gaap:PaymentsOfDividendsCommonStock · last filed 2026-08-24

  • BIO-TECHNE Corp payments of ordinary dividends, common stock for the quarter ending 2026-06-30 was $12.48M, a 0.78% increase year-over-year.
  • BIO-TECHNE Corp payments of ordinary dividends, common stock for the quarter ending 2026-03-31 was $12.52M, a 0.49% decline year-over-year.
  • BIO-TECHNE Corp payments of ordinary dividends, common stock for the quarter ending 2025-12-31 was $12.47M, a 2.09% decline year-over-year.
  • BIO-TECHNE Corp payments of ordinary dividends, common stock for the quarter ending 2025-09-30 was $12.44M, a 1.92% decline year-over-year.
  • BIO-TECHNE Corp payments of ordinary dividends, common stock for fiscal 2026 was $49.92M, a 0.94% decline from fiscal 2025.
  • BIO-TECHNE Corp payments of ordinary dividends, common stock for fiscal 2025 was $50.39M, a 0.06% decline from fiscal 2024.
  • BIO-TECHNE Corp payments of ordinary dividends, common stock for fiscal 2024 was $50.42M, a 0.27% increase from fiscal 2023.
  • BIO-TECHNE Corp payments of ordinary dividends, common stock for fiscal 2023 was $50.28M, a 0.20% increase from fiscal 2022.
Period endPayments of Ordinary Dividends, Common Stock 3 monthPayments of Ordinary Dividends, Common Stock 6 monthPayments of Ordinary Dividends, Common Stock 9 monthPayments of Ordinary Dividends, Common Stock 12 monthPayments of Ordinary Dividends, Common Stock 12 month as first filed
2026-06-30$12.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24
$25.00M
derived: sum of 2 quarters · filed 2026-08-24
$37.47M
derived: sum of 3 quarters · filed 2026-08-24
$49.92M
10-K · filed 2026-08-24
2026-03-31$12.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06
$24.99M
derived: sum of 2 quarters · filed 2026-05-06
$37.43M
10-Q · filed 2026-05-06
$49.82M
derived: sum of 4 quarters · filed 2026-08-24
2025-12-31$12.47M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04
$24.91M
10-Q · filed 2026-02-04
$37.30M
derived: sum of 3 quarters · filed 2026-08-24
$49.88M
derived: sum of 4 quarters · filed 2026-08-24
2025-09-30$12.44M
10-Q · filed 2025-11-05
$24.83M
derived: sum of 2 quarters · filed 2026-08-24
$37.41M
derived: sum of 3 quarters · filed 2026-08-24
$50.15M
derived: sum of 4 quarters · filed 2026-08-24
2025-06-30$12.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24
$24.97M
derived: sum of 2 quarters · filed 2026-08-24
$37.70M
derived: sum of 3 quarters · filed 2026-08-24
$50.39M
10-K · filed 2026-08-24
2025-03-31$12.58M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06
$25.32M
derived: sum of 2 quarters · filed 2026-05-06
$38.00M
10-Q · filed 2026-05-06
$50.63M
derived: sum of 4 quarters · filed 2026-08-24
2024-12-31$12.74M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04
$25.42M
10-Q · filed 2026-02-04
$38.05M
derived: sum of 3 quarters · filed 2026-08-24
$50.63M
derived: sum of 4 quarters · filed 2026-08-24
2024-09-30$12.69M
10-Q · filed 2025-11-05
$25.32M
derived: sum of 2 quarters · filed 2026-08-24
$37.89M
derived: sum of 3 quarters · filed 2026-08-24
$50.45M
derived: sum of 4 quarters · filed 2026-08-24
2024-06-30$12.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24
$25.21M
derived: sum of 2 quarters · filed 2026-08-24
$37.77M
derived: sum of 3 quarters · filed 2026-08-24
$50.42M
10-K · filed 2026-08-24
2024-03-31$12.58M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-08
$25.14M
derived: sum of 2 quarters · filed 2025-05-08
$37.79M
10-Q · filed 2025-05-08
$50.39M
derived: sum of 4 quarters · filed 2025-08-22
2023-12-31$12.56M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-06
$25.21M
10-Q · filed 2025-02-06
$37.81M
derived: sum of 3 quarters · filed 2025-08-22
$50.39M
derived: sum of 4 quarters · filed 2025-08-22
2023-09-30$12.65M
10-Q · filed 2024-11-05
$25.25M
derived: sum of 2 quarters · filed 2025-08-22
$37.83M
derived: sum of 3 quarters · filed 2025-08-22
$50.39M
derived: sum of 4 quarters · filed 2025-08-22
2023-06-30$12.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22
$25.18M
derived: sum of 2 quarters · filed 2025-08-22
$37.74M
derived: sum of 3 quarters · filed 2025-08-22
$50.28M
10-K · filed 2025-08-22
2023-03-31$12.58M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-06
$25.14M
derived: sum of 2 quarters · filed 2024-05-06
$37.69M
10-Q · filed 2024-05-06
$50.23M
derived: sum of 4 quarters · filed 2024-08-22
2022-12-31$12.56M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-07
$25.11M
10-Q · filed 2024-02-07
$37.65M
derived: sum of 3 quarters · filed 2024-08-22
$50.22M
derived: sum of 4 quarters · filed 2024-08-22
2022-09-30$12.54M
10-Q · filed 2023-11-07
$25.08M
derived: sum of 2 quarters · filed 2024-08-22
$37.66M
derived: sum of 3 quarters · filed 2024-08-22
$50.24M
derived: sum of 4 quarters · filed 2024-08-22
2022-06-30$12.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-22
$25.12M
derived: sum of 2 quarters · filed 2024-08-22
$37.69M
derived: sum of 3 quarters · filed 2024-08-22
$50.19M
10-K · filed 2024-08-22
2022-03-31$12.58M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-08
$25.15M
derived: sum of 2 quarters · filed 2023-05-08
$37.65M
10-Q · filed 2023-05-08
$50.09M
derived: sum of 4 quarters · filed 2023-08-23
2021-12-31$12.58M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07
$25.07M
10-Q · filed 2023-02-07
$37.52M
derived: sum of 3 quarters · filed 2023-08-23
$49.96M
derived: sum of 4 quarters · filed 2023-08-23
2021-09-30$12.49M
10-Q · filed 2022-11-07
$24.94M
derived: sum of 2 quarters · filed 2023-08-23
$37.39M
derived: sum of 3 quarters · filed 2023-08-23
$49.78M
derived: sum of 4 quarters · filed 2023-08-23
2021-06-30$12.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23
$24.89M
derived: sum of 2 quarters · filed 2023-08-23
$37.29M
derived: sum of 3 quarters · filed 2023-08-23
$49.62M
10-K · filed 2023-08-23
2021-03-31$12.45M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-09
$24.84M
derived: sum of 2 quarters · filed 2022-05-09
$37.17M
10-Q · filed 2022-05-09
$49.43M
derived: sum of 4 quarters · filed 2022-08-24
2020-12-31$12.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-07
$24.73M
10-Q · filed 2022-02-07
$36.99M
derived: sum of 3 quarters · filed 2022-08-24
$49.27M
derived: sum of 4 quarters · filed 2022-08-24
2020-09-30$12.34M
10-Q · filed 2021-11-08
$12.34M
10-Q · filed 2020-11-09
$36.87M
derived: sum of 3 quarters · filed 2022-08-24
$49.07M
derived: sum of 4 quarters · filed 2022-08-24
2020-06-30$12.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-24
$24.54M
derived: sum of 2 quarters · filed 2022-08-24
$36.73M
derived: sum of 3 quarters · filed 2022-08-24
$48.90M
10-K · filed 2022-08-24
2020-03-31$12.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-07
$24.48M
derived: sum of 2 quarters · filed 2021-05-07
$36.64M
10-Q · filed 2021-05-07
$48.77M
derived: sum of 4 quarters · filed 2021-08-25
2019-12-31$12.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-08
$24.36M
10-Q · filed 2021-02-08
$36.49M
derived: sum of 3 quarters · filed 2021-08-25
$48.58M
derived: sum of 4 quarters · filed 2021-08-25
2019-09-30$12.17M
10-Q · filed 2019-11-06
$12.17M
10-Q · filed 2020-11-09
$36.38M
derived: sum of 3 quarters · filed 2021-08-25
$48.47M
derived: sum of 4 quarters · filed 2021-08-25
2019-06-30$12.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-25
$24.21M
derived: sum of 2 quarters · filed 2021-08-25
$36.30M
derived: sum of 3 quarters · filed 2021-08-25
$48.36M
10-K · filed 2021-08-25
2019-03-31$12.09M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11
$24.17M
derived: sum of 2 quarters · filed 2020-05-11
$36.24M
10-Q · filed 2020-05-11
$48.27M
derived: sum of 4 quarters · filed 2020-08-26
2018-12-31$12.09M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06
$24.15M
10-Q · filed 2020-02-06
$36.18M
derived: sum of 3 quarters · filed 2020-08-26
$48.18M
derived: sum of 4 quarters · filed 2020-08-26
2018-09-30$12.07M
10-Q · filed 2019-11-06
$24.10M
derived: sum of 2 quarters · filed 2020-08-26
$36.09M
derived: sum of 3 quarters · filed 2020-08-26
$48.08M
derived: sum of 4 quarters · filed 2020-08-26
2018-06-30$12.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-26
$24.03M
derived: sum of 2 quarters · filed 2020-08-26
$36.02M
derived: sum of 3 quarters · filed 2020-08-26
$47.97M
10-K · filed 2020-08-26
2018-03-31$11.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-07
$23.98M
derived: sum of 2 quarters · filed 2019-05-07
$35.94M
10-Q · filed 2019-05-07
$47.45M
derived: sum of 4 quarters · filed 2019-11-06
2017-12-31$11.99M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07
$23.95M
10-Q · filed 2019-02-07
$35.46M
derived: sum of 3 quarters · filed 2019-11-06
$47.40M
derived: sum of 4 quarters · filed 2019-11-06
2017-09-30$11.96M
10-Q · filed 2018-11-07
$23.47M
derived: sum of 2 quarters · filed 2019-11-06
$11.96M
10-Q · filed 2017-11-09
$47.35M
derived: sum of 4 quarters · filed 2019-11-06
2017-06-30$11.51M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06
$23.45M
derived: sum of 2 quarters · filed 2019-11-06
$35.39M
derived: sum of 3 quarters · filed 2019-11-06
$47.33M
10-K/A · filed 2019-11-06
2017-03-31$11.94M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09
$23.88M
derived: sum of 2 quarters · filed 2018-05-09
$35.81M
10-Q · filed 2018-05-09
$47.72M
derived: sum of 4 quarters · filed 2018-08-27
2016-12-31$11.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08
$23.87M
10-Q · filed 2018-02-08
$35.78M
derived: sum of 3 quarters · filed 2018-08-27
$47.68M
derived: sum of 4 quarters · filed 2018-08-27
2016-09-30$11.93M
10-Q · filed 2016-11-09
$23.84M
derived: sum of 2 quarters · filed 2018-08-27
$11.93M
10-Q · filed 2017-11-09
$47.65M
derived: sum of 4 quarters · filed 2018-08-27
2016-06-30$11.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-27
$23.81M
derived: sum of 2 quarters · filed 2018-08-27
$35.71M
derived: sum of 3 quarters · filed 2018-08-27
$47.61M
10-K · filed 2018-08-27
2016-03-31$11.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-10
$23.80M
derived: sum of 2 quarters · filed 2017-05-10
$35.70M
10-Q · filed 2017-05-10
$47.59M
derived: sum of 4 quarters · filed 2017-09-07
2015-12-31$11.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09
$23.80M
10-Q · filed 2017-02-09
$35.69M
derived: sum of 3 quarters · filed 2017-09-07
$47.57M
derived: sum of 4 quarters · filed 2017-09-07
2015-09-30$11.89M
10-Q · filed 2016-11-09
$23.78M
derived: sum of 2 quarters · filed 2017-09-07
$35.67M
derived: sum of 3 quarters · filed 2017-09-07
$47.53M
derived: sum of 4 quarters · filed 2017-09-07
2015-06-30$11.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07
$23.77M
derived: sum of 2 quarters · filed 2017-09-07
$35.63M
derived: sum of 3 quarters · filed 2017-09-07
$47.11M
10-K · filed 2017-09-07
$47.11M
10-K · filed 2015-08-31
2015-03-31$11.88M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10
$23.75M
derived: sum of 2 quarters · filed 2016-05-10
$35.22M
10-Q · filed 2016-05-10
$46.69M
derived: sum of 4 quarters · filed 2016-08-29
2014-12-31$11.86M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09
$23.34M
10-Q · filed 2016-02-09
$34.80M
derived: sum of 3 quarters · filed 2016-08-29
$46.24M
derived: sum of 4 quarters · filed 2016-08-29
2014-09-30$11.47M
10-Q · filed 2015-11-09
$22.94M
derived: sum of 2 quarters · filed 2016-08-29
$34.38M
derived: sum of 3 quarters · filed 2016-08-29
$45.81M
derived: sum of 4 quarters · filed 2016-08-29
2014-06-30$11.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29
$22.91M
derived: sum of 2 quarters · filed 2016-08-29
$34.34M
derived: sum of 3 quarters · filed 2016-08-29
$45.39M
10-K · filed 2016-08-29
2014-03-31$11.44M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-11
$22.87M
derived: sum of 2 quarters · filed 2015-05-11
$33.92M
10-Q · filed 2015-05-11
$44.98M
derived: sum of 4 quarters · filed 2015-08-31
2013-12-31$11.43M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-09
$22.48M
10-Q · filed 2015-02-09
$33.53M
derived: sum of 3 quarters · filed 2015-08-31
$44.59M
derived: sum of 4 quarters · filed 2015-08-31
2013-09-30$11.05M
10-Q · filed 2014-11-10
$22.10M
derived: sum of 2 quarters · filed 2015-08-31
$33.15M
derived: sum of 3 quarters · filed 2015-08-31
$44.20M
derived: sum of 4 quarters · filed 2015-08-31
2013-06-30$11.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31
$22.10M
derived: sum of 2 quarters · filed 2015-08-31
$33.15M
derived: sum of 3 quarters · filed 2015-08-31
$43.46M
10-K · filed 2015-08-31
2013-03-31$11.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-12
$22.10M
derived: sum of 2 quarters · filed 2014-05-12
$32.41M
10-Q · filed 2014-05-12
$42.72M
derived: sum of 4 quarters · filed 2014-08-29
2012-12-31$11.05M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-04
$21.36M
10-Q · filed 2014-02-04
$31.67M
derived: sum of 3 quarters · filed 2014-08-29
$41.99M
derived: sum of 4 quarters · filed 2014-08-29
2012-09-30$10.31M
10-Q · filed 2013-11-12
$20.62M
derived: sum of 2 quarters · filed 2014-08-29
$30.94M
derived: sum of 3 quarters · filed 2014-08-29
$41.30M
derived: sum of 4 quarters · filed 2014-08-29
2012-06-30$10.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-29
$20.63M
derived: sum of 2 quarters · filed 2014-08-29
$30.99M
derived: sum of 3 quarters · filed 2014-08-29
$41.02M
10-K · filed 2014-08-29
2012-03-31$10.32M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-10
$20.68M
derived: sum of 2 quarters · filed 2013-05-10
$30.71M
10-Q · filed 2013-05-10
$40.74M
derived: sum of 4 quarters · filed 2013-08-29
2011-12-31$10.36M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-11
$20.39M
10-Q · filed 2013-02-11
$30.42M
derived: sum of 3 quarters · filed 2013-08-29
$40.44M
derived: sum of 4 quarters · filed 2013-08-29
2011-09-30$10.03M
10-Q · filed 2012-11-09
$20.05M
derived: sum of 2 quarters · filed 2013-08-29
$30.08M
derived: sum of 3 quarters · filed 2013-08-29
$40.09M
derived: sum of 4 quarters · filed 2013-08-29
2011-06-30$10.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29
$20.05M
derived: sum of 2 quarters · filed 2013-08-29
$30.06M
derived: sum of 3 quarters · filed 2013-08-29
$39.69M
10-K · filed 2013-08-29
2011-03-31$10.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-10
$20.03M
derived: sum of 2 quarters · filed 2012-05-10
$29.66M
10-Q · filed 2012-05-10
$39.35M
derived: sum of 4 quarters · filed 2012-08-29
2010-12-31$10.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-07
$19.64M
10-Q · filed 2012-02-07
$29.33M
derived: sum of 3 quarters · filed 2012-08-29
$39.03M
derived: sum of 4 quarters · filed 2012-08-29
2010-09-30$9.63M
10-Q · filed 2011-11-09
$19.32M
derived: sum of 2 quarters · filed 2012-08-29
$29.02M
derived: sum of 3 quarters · filed 2012-08-29
$38.71M
derived: sum of 4 quarters · filed 2012-08-29
2010-06-30$9.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-29
$19.39M
derived: sum of 2 quarters · filed 2012-08-29
$29.08M
derived: sum of 3 quarters · filed 2012-08-29
$38.39M
10-K · filed 2012-08-29
2010-03-31$9.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-05-10
$19.38M
derived: sum of 2 quarters · filed 2011-05-10
$28.70M
10-Q · filed 2011-05-10
2009-12-31$9.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-02-09
$19.00M
10-Q · filed 2011-02-09
2009-09-30$9.31M
10-Q · filed 2010-11-09
2009-06-30$28.19M
10-K · filed 2011-08-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Twist Bioscience Corp (TWST)United States$11.540B-47.21
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Immunovant, Inc. (IMVT)United States$7.028B-14.78